ANTANANARIVO – The U.S. government donated 302,750 doses of the single-shot Johnson & Johnson COVID-19 vaccine to Madagascar as part of the Administration’s global effort to fight the COVID-19 pandemic. The vaccines are part of the U.S. pledge to provide at least 25 million of 80 million doses globally to Africa. The U.S. government coordinated closely with the African Union, Africa CDC, and COVAX on the country allocations. COVAX supported delivery of these vaccine doses, which arrived in Antananarivo on July 27, 2021.

“Sharing these vaccines will not only help protect the Malagasy people from COVID-19, but also begin reducing barriers to building back the Malagasy economy,” Amy Hyatt, U.S. Chargé d’Affaires to the Republic of Madagascar and the Union of the Comoros, said.

These 302,750 doses are part of the Biden-Harris Administration’s commitment to share U.S. vaccine supply with the world. As we continue to fight the COVID-19 pandemic at home and work to end the pandemic worldwide, President Biden has promised that the United States will be an arsenal of vaccines for the world.

“From the beginning of my presidency, we have been clear-eyed that we need to attack this virus globally as well. This is about our responsibility — our humanitarian obligation to save as many lives as we can — and our responsibility to our values. We’re going to help lead the world out of this pandemic, working alongside our global partners,” President Biden said.

Throughout the pandemic, the United States has worked closely with the Government of Madagascar to protect public health and strengthen the response to COVID-19. The United States has provided $2.5 million in emergency funding to support the Government of Madagascar’s COVID-19 response, supported the delivery and rollout of vaccines, and contributed $5 million to the Tosika Fameno cash transfer program to ensure vulnerable families in the most affected cities had enough to eat.

Press Release by the U.S. Embassy Antananarivo

Published in Madagascar and the US

An initiative by

Initiate by

 

Funding provided by


Supported by

 

AmCham sponsors

sponsor

Disclaimer:


This website was funded by a grant from the United States Department of State. The opinions, findings and conclusions stated herein are those of the author(s) and do not necessarily reflect those of the United States Department of State.